![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
Majid Assadi MD,MSc(Adv.Onc.)
@AssadiMajidMD
#Clinician-Scientist,#Theranostics, #MolecularImaging,#Nuclearoncology
ID:1367195315036704769
https://www.google.com/amp/s/www.researchgate.net/profile/Majid_Assadi2/amp/9 03-03-2021 19:29:19
46 Tweets
253 Followers
339 Following
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
Small Animal Imaging Workshop
overview on state-of-the-art small animal imaging tools including PET, SPECT, CT and optical imaging.
#Preclinical
t.me/preclinical_Bu…
![Majid Assadi MD,MSc(Adv.Onc.) (@AssadiMajidMD) on Twitter photo 2023-07-09 15:27:31 Small Animal Imaging Workshop overview on state-of-the-art small animal imaging tools including PET, SPECT, CT and optical imaging. #Preclinical t.me/preclinical_Bu… Small Animal Imaging Workshop overview on state-of-the-art small animal imaging tools including PET, SPECT, CT and optical imaging. #Preclinical t.me/preclinical_Bu…](https://pbs.twimg.com/media/F0mttOJXsAAGaWj.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
Predictive and prognostic potential of pretreatment #68GaPSMAPET tumor #heterogeneityindex in patients with metastatic castration-resistant #prostatecancer treated with #177LuPSMA ASCO #GU23
![Majid Assadi MD,MSc(Adv.Onc.) (@AssadiMajidMD) on Twitter photo 2023-02-20 04:04:51 Predictive and prognostic potential of pretreatment #68GaPSMAPET tumor #heterogeneityindex in patients with metastatic castration-resistant #prostatecancer treated with #177LuPSMA @ASCO #GU23 Predictive and prognostic potential of pretreatment #68GaPSMAPET tumor #heterogeneityindex in patients with metastatic castration-resistant #prostatecancer treated with #177LuPSMA @ASCO #GU23](https://pbs.twimg.com/media/FpYcd_VXoAE8CtD.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
Our brand new #PET_CT and #SPECT_CT installed in our
“Comprehensive Nuclear Medicine Center” including four main divisions :
Basic Sciences, #Preclinical and Clinical Imaging and
Innovative #Theranostics
theranosticsiran.com
![Majid Assadi MD,MSc(Adv.Onc.) (@AssadiMajidMD) on Twitter photo 2022-12-09 19:51:24 Our brand new #PET_CT and #SPECT_CT installed in our “Comprehensive Nuclear Medicine Center” including four main divisions : Basic Sciences,#Preclinical and Clinical Imaging and Innovative #Theranostics theranosticsiran.com Our brand new #PET_CT and #SPECT_CT installed in our “Comprehensive Nuclear Medicine Center” including four main divisions : Basic Sciences,#Preclinical and Clinical Imaging and Innovative #Theranostics theranosticsiran.com](https://pbs.twimg.com/media/Fjj5C9ZXgAIJ3MF.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
Our project on #Radiomics In #ProstateCancer and #177LuPSMA just came out. #GLCM entropy alone showed the highest predictive performance in treatment planning.
frontiersin.org/articles/10.33…
![Majid Assadi MD,MSc(Adv.Onc.) (@AssadiMajidMD) on Twitter photo 2022-12-08 13:05:48 Our project on #Radiomics In #ProstateCancer and #177LuPSMA just came out. #GLCM entropy alone showed the highest predictive performance in treatment planning. frontiersin.org/articles/10.33… Our project on #Radiomics In #ProstateCancer and #177LuPSMA just came out. #GLCM entropy alone showed the highest predictive performance in treatment planning. frontiersin.org/articles/10.33…](https://pbs.twimg.com/media/FjdSoQRXEAAzGfw.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
After graduation of MSc in Adv. Onc. from @ULMUniversity,taking part in 20th Western European Masterclass ESOncology early February till in person meeting 23-27 September, Barcelona;TOWARDS Nuclear Oncology /ICPO Foundation @Oncoalert @officialEANM SNMMI
![Majid Assadi MD,MSc(Adv.Onc.) (@AssadiMajidMD) on Twitter photo 2022-09-25 14:37:46 After graduation of MSc in Adv. Onc. from @ULMUniversity,taking part in 20th Western European Masterclass @ESOncology early February till in person meeting 23-27 September, Barcelona;TOWARDS @NuclearOncology /@ICPO_Foundation @Oncoalert @officialEANM @SNM_MI After graduation of MSc in Adv. Onc. from @ULMUniversity,taking part in 20th Western European Masterclass @ESOncology early February till in person meeting 23-27 September, Barcelona;TOWARDS @NuclearOncology /@ICPO_Foundation @Oncoalert @officialEANM @SNM_MI](https://pbs.twimg.com/media/FdgiCYhWYAMOtGv.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
Comprehensive approach to #VQ SPECT or SPECT/CT studies for the ssessment of :
#Pulmonary embolism
#Pulmonary hypertension
#Shunting
#Gas Exchange
#Airway obstruction
![Majid Assadi MD,MSc(Adv.Onc.) (@AssadiMajidMD) on Twitter photo 2022-07-24 18:51:28 Comprehensive approach to #VQ SPECT or SPECT/CT studies for the ssessment of : #Pulmonary embolism #Pulmonary hypertension #Shunting #Gas Exchange #Airway obstruction Comprehensive approach to #VQ SPECT or SPECT/CT studies for the ssessment of : #Pulmonary embolism #Pulmonary hypertension #Shunting #Gas Exchange #Airway obstruction](https://pbs.twimg.com/media/FYc_iYVXwAAknz1.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
Graduation after two years of professional experience in the field of oncology and working on thesis “ #AdvancedOncology ”in Germany
#Nuclearoncology
#Theranostics
![Majid Assadi MD,MSc(Adv.Onc.) (@AssadiMajidMD) on Twitter photo 2022-07-14 22:13:50 Graduation after two years of professional experience in the field of oncology and working on thesis “#AdvancedOncology”in Germany #Nuclearoncology #Theranostics Graduation after two years of professional experience in the field of oncology and working on thesis “#AdvancedOncology”in Germany #Nuclearoncology #Theranostics](https://pbs.twimg.com/media/FXqOXhDVsAAPpqn.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
Keynote talk on Radiotheranostics in Adult and Pediatrics Oncology Societies Meeting including original treated patients with 177Lu-Trastuzumab, 177 Lu-FAPI, 177Lu-Rituximab,-PSMA, PRRT and also combination with other therapies in line of PRECISION ONCOLOGY #Theranostics
![Majid Assadi MD,MSc(Adv.Onc.) (@AssadiMajidMD) on Twitter photo 2022-05-15 14:58:18 Keynote talk on Radiotheranostics in Adult and Pediatrics Oncology Societies Meeting including original treated patients with 177Lu-Trastuzumab, 177 Lu-FAPI, 177Lu-Rituximab,-PSMA, PRRT and also combination with other therapies in line of PRECISION ONCOLOGY #Theranostics Keynote talk on Radiotheranostics in Adult and Pediatrics Oncology Societies Meeting including original treated patients with 177Lu-Trastuzumab, 177 Lu-FAPI, 177Lu-Rituximab,-PSMA, PRRT and also combination with other therapies in line of PRECISION ONCOLOGY #Theranostics](https://pbs.twimg.com/media/FSzrSG1XoAAC2eU.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
![Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo Majid Assadi MD,MSc(Adv.Onc.)(@AssadiMajidMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1735901044465422338/b2xbqFQ2_200x200.jpg)
My talk on “Targeted Alpha Therapy (TAT)” in a multidisciplinary webinar few days ago aiming to provide an outline of latest advances on TAT in current oncological context. #Theranostic
The file is loaded in my researchgate website: researchgate.net/publication/35…